It is also indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma.
All clinical trials concluded that cinacalcet is effective for the reduction of parathyroid hormone, serum calcium, phosphorus, and calcium-phosphate product levels.
Cinacalcet is available as a once-daily oral therapy.